Evidence map›Paper›PMID 25443708›Full record

ReviewJournal of the American College of Cardiology2014

Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases?

Eloisa Arbustini, Frank Weidemann, Jennifer L Hall

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of the American College of Cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02652676 (Reversible Pulmonary Artery Banding as Simplified Management of End-stage Dilated Left Ventriculopathy in Early Life), which is not on this map. Cited by 102 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02652676 naterminatednot on this mapstarted 2016, after this paper: background citation

Reversible Pulmonary Artery Banding as Simplified Management of End-stage Dilated Left Ventriculopathy in Early Life

TypeinterventionalSponsorLoma Linda UniversityRan2016 to 2021Enrolled4ConditionsAcute on Chronic Systolic Congestive Heart FailureArmsReversible Pulmonary Artery Banding, GORE-TEX DualMesh EMERGE PLUS Biomaterial
3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Clinical and genetic insights into non-compaction: a meta-analysis and systematic review on 7598 individuals.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Pooled it
  3. Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).Genetics in medicine : official journal of the American College of Medical Genetics · 2018
    Guideline
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Eloisa ArbustiniCentre for Inherited Cardiovascular Disease, IRCCS Foundation Policlinico San Matteo, Pavia, Italy.
Frank WeidemannDepartment of Internal Medicine, University Hospital Würzburg, and Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany.
Jennifer L HallLillehei Heart Institute and Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, Minnesota. Electronic address: JLHALL@umn.edu.

Funding

Genetic Risk Factors of Myocyte Contractility in Human Heart FailureR21HL104596 · NHLBI · UNIVERSITY OF MINNESOTA · PI HALL, JENNIFER L · 2011 to 2012
$421k
Defining How a Variant in TCF7L2 Confers Increased Risk for Type 2 DiabetesR21DK078029 · NIDDK · UNIVERSITY OF MINNESOTA · PI HALL, JENNIFER L · 2007 to 2008
$407k
NHLBI NIH HHS R21 HL104596NIDDK NIH HHS 1R21DK078029-01NIDDK NIH HHS R21 DK078029
6 · The paper itself

Abstract

Whether left ventricular noncompaction (LVNC) is a distinct cardiomyopathy or a morphologic trait shared by different cardiomyopathies remains controversial. Current guidelines from professional organizations recommend different strategies for diagnosing and treating patients with LVNC. This state-of-the-art review discusses new insights into the basic mechanisms leading to LVNC, its clinical manifestations, treatment modalities, anatomy and pathology, embryology, genetics, epidemiology, and imaging. Three markers currently define LVNC: prominent left ventricular trabeculae, deep intertrabecular recesses, and a thin compacted layer. Although new genetic data from mice and humans supports LVNC as a distinct cardiomyopathy, evidence for LVNC as a shared morphological trait is not ruled out. Criteria supporting LVNC as a shared morphological trait may depend on consensus guidelines from the multiple professional organizations. Enhanced imaging and increased use of genetics are both predicted to significantly impact our overall understanding of the basic mechanisms causing LVNC and its optimal management.

Indexed as

AnimalsCardiomyopathiesEchocardiographyFractalsHeart DiseasesHeart VentriclesHumansImage Processing, Computer-AssistedIsolated Noncompaction of the Ventricular MyocardiumMagnetic Resonance SpectroscopyMiceMutationPhenotypeSignal TransductionThrombosisTreatment Outcomecompactedepidemiologygeneticsimagingpathologytrabeculae

Identifiers

PMID25443708
PMCPMC10352990

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.